PreSat

The PreSat (PharmaSat Risk Evaluation Satellite) CubeSat technology demonstration nanosatellite is a risk reduction and technology demonstration mission. It was developed in only 180 days in NASA Ames Research Center (ARC) Free Flyer (µSat FF) program, that is focused on implementing peer-reviewed fundamental space biology investigations on a microsatellite free flyer platform. It serves as a risk-reduction mission for PharmaSat.

The objectives of the mission are:

• Demonstrate / validate Performance of NASA-Ames 2nd Generation Modular Triple CubeSat Nanosatellite Platform
• Spaceflight Performance Evaluation of Generic BioFluidic Sample Management and Handling Subsystem using Optical Detection
• Evaluation of Payload Environmental Management Subsystem

The satellite failed to reach orbit due to a launch vehicle staging malfunction.

References:

• Source: http://microsatellitefreeflyer.arc.nasa.gov/presat.html

Last update: 27.09.2009
Contact: gunter.krebs@skyrocket.de
© Gunter Dirk Krebs